Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1 1

Status

Active not recruiting 6

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6

Conditions

Carcinoma, Non-Small-Cell Lung 5Non Small Cell Lung Cancer NSCLC 1

Interventions

Carboplatin 12pembrolizumab 11Gemcitabine 10Cisplatin 10Rituximab 7Pemetrexed 6Nivolumab 6osimertinib 5durvalumab 5atezolizumab 5Specimen Handling 5Paclitaxel 5Dexamethasone 5trastuzumab deruxtecan 4amivantamab 4Prednisone 4Ipilimumab 4Cyclophosphamide 4Capecitabine 4Bortezomib 4tremelimumab 3niraparib 3lazertinib 3entrectinib 3daratumumab 3belzutifan 3X-Rays 3Vinorelbine 3Oxaliplatin 3Midazolam 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has announcements × Pemetrexed × 90 days × Clear all
NCT02609776 2026-05-08

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting
751 enrolled 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04538664 2026-05-08

PAPILLON

Janssen Research & Development, LLC

Phase 3 Active not recruiting
308 enrolled 12 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04988295 2026-05-08

MARIPOSA-2

Janssen Research & Development, LLC

Phase 3 Active not recruiting
776 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03456076 2026-05-05

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 3 Active not recruiting
257 enrolled 14 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02486718 2026-04-30

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Hoffmann-La Roche

Phase 3 Active not recruiting
1,280 enrolled 24 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03164616 2026-03-13

POSEIDON

AstraZeneca

Phase 3 Active not recruiting
1,186 enrolled 26 charts 1 FDA
Thoracic

Non Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡